Inflammatory myofibroblastic tumours of the urinary bladder: multi-centre 18-year experience

Urol Int. 2015;94(1):31-6. doi: 10.1159/000358732. Epub 2014 Jul 18.

Abstract

Objective: To review a series of inflammatory myofibroblastic tumours (IMTs) of the urinary bladder in 10 hospitals in Hong Kong.

Methods: A database search in the pathology archives of 10 hospitals in Hong Kong from 1995 to 2013 was performed using the key words 'inflammatory myofibroblastic tumour', 'inflammatory pseudotumour' and 'spindle cell lesion'. Patient characteristics, clinical features, histological features, immunohistochemical staining results and treatment outcomes were reviewed.

Results: Nine cases of IMT of the urinary bladder were retrieved. The mean age was 45.4 ± 22.8 years (range 11-78). Eight patients (88.9%) presented with haematuria and 5 patients (55.6%) had anaemia with a mean haemoglobin level of 6.8 ± 1.3 g/dl. Histologically, the majority of patients (77.8%) had a compact spindle cell pattern. Anaplastic lymphoma kinase staining was positive in 75% of cases. During a mean follow-up period of 43.4 months (range 8-94), none of them developed any local recurrence or distant metastasis.

Conclusions: A high index of suspicion of IMT should be maintained for young patients presenting with bleeding bladder tumours and significant anaemia. IMTs of the urinary bladder run a benign disease course, and good prognosis can be achieved after surgical resection.

Publication types

  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anaplastic Lymphoma Kinase
  • Anemia / etiology
  • Biomarkers / analysis
  • Biopsy
  • Child
  • Cystectomy
  • Cystoscopy
  • Databases, Factual
  • Female
  • Granuloma, Plasma Cell* / complications
  • Granuloma, Plasma Cell* / metabolism
  • Granuloma, Plasma Cell* / pathology
  • Granuloma, Plasma Cell* / surgery
  • Hematuria / etiology
  • Hong Kong
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Receptor Protein-Tyrosine Kinases / analysis
  • Time Factors
  • Treatment Outcome
  • Urinary Bladder Diseases* / complications
  • Urinary Bladder Diseases* / metabolism
  • Urinary Bladder Diseases* / pathology
  • Urinary Bladder Diseases* / surgery
  • Young Adult

Substances

  • Biomarkers
  • ALK protein, human
  • Anaplastic Lymphoma Kinase
  • Receptor Protein-Tyrosine Kinases